Home > 36th meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 30 June-2 July 2015.

UNAIDS. (2015) 36th meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 30 June-2 July 2015. Geneva: UNAIDS. 4 p.

[img]
Preview
PDF (UNAIDS Programme Coordinating Board, July 2015)
94kB

The UNAIDS Programme Coordinating Board, Recalling that all aspects of UNAIDS work are directed by the following guiding principles:
● Aligned to national stakeholders’ priorities;
● Based on the meaningful and measurable involvement of civil society, especially people living with HIV and key populations most at risk of HIV infection;
● Based on human rights and gender equality;
● Based on the best available scientific evidence and technical knowledge;
● Promoting comprehensive responses to AIDS that integrate prevention, treatment, care and support; and
● Based on the principle of non-discrimination

Agenda item 5: Follow-up to the thematic segment from the 35th Programme Coordinating Board meeting:
8.1 Takes note with appreciation of the summary report of the Programme Coordinating Board thematic session on halving HIV transmission among people who inject drugs and recalls decision points 8.1 through 8.11 of the 24th UNAIDS Programme Coordinating Board meeting;

8.2 Recognizes the need to strengthen action to address transmission of HIV among people who use drugs, by adopting and implementing comprehensive drug policies that are based on evidence and respect for human rights, that promote the right of everyone to the enjoyment of the highest attainable standard of health, that respect the dignity of all persons, and that are informed by the harm reduction interventions related to HIV and people who use drugs, as enumerated in the WHO, UNODC, UNAIDS Technical Guide For Countries to Set Targets for HIV Prevention, Treatment and Care for Injecting Drug Users and the WHO Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations, in line with national contexts, and further, that HIV services for people who use drugs should be planned, implemented, monitored and evaluated with inclusion of people who use drugs;

8.3 Encourages the Joint Programme to:
a. Work with member states to develop evidence-based programming, which is gender sensitive and informed by the existing evidence and guidelines relevant to HIV prevention, treatment and care for injecting drug users, including structural interventions that create enabling environments;

b. Within the framework of efforts to advocate for sufficient resources to end the AIDS epidemic by 2030, work with member states and other donors to ensure that funding is allocated to implement effective, evidence-based programmes to address HIV and injecting drug use, including through the work of impacted civil society networks;

c. Strengthen recommendations regarding the importance of justice, law enforcement, and health sector collaboration, alternatives to incarceration, the need for science and evidence to drive policy, and comprehensive evidence-based prevention and treatment programmes, including medication-assisted treatment;

8.4 Encourages the Joint Programme and relevant partners to fully engage in, and bring their substantive expertise to, the 2016 UNGASS on the World Drug Problem in order to promote public health outcomes such as reducing HIV transmission and ending AIDS as a public health threat by 2030, including in the framework of the International Drug Control System, and further encourages that issues impacting on HIV among people who use drugs feature prominently in the 2016 High Level Meeting on HIV;


Item Type:Evidence resource
Drug Type:Opioid
Intervention Type:AOD disorder harm reduction
Source:UNAIDS
Date:July 2015
Pages:4 p.
Publisher:UNAIDS
Corporate Creators:UNAIDS
Place of Publication:Geneva
EndNote:View
Subjects:G Health and disease > Disorder by cause > Communicable disease > HIV
G Health and disease > Disorder by cause > Communicable disease > Acquired immunodeficiency syndrome (AIDS)
J Health care, prevention and rehabilitation > Health related prevention > Health information and education > Communicable disease control > HIV prevention
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
T Demographic characteristics > Intravenous / injecting drug user
VA Geographic area > International aspects

Repository Staff Only: item control page